BrainStorm Cell Execs Buy Millions of Shares, Show Strong Confidence in Future
BrainStorm Cell Therapeutics insider buys 1.8 M free RSUs, boosting CEO shares 10% and signaling confidence in Phase 3b ALS trial prospects.
- BrainStorm Cell Therapeutics Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read